abstract |
A therapeutic compound has a modified phenolic compound of the general formula (I) wherein at least one of R, R 1 , R 2 , R 3 , and R 4 is an electrophilic group chosen fromhalogen, aldehyde, haloalkane, alkene, butyryl, flurophenol, sulfonamide, flurophenol sulfoxide and the remaining R, R 1 , R 2 , R 3 , and R 4 is are each independently hydrogen, a hydroxyl group, an alkoxy group, a rutinosyl group, a carboxyl group, chromone, benzopyran, a rhamnosyl group, a substituted alkoxy group or a substituted acyloxy group wherein the substituent is chosen from hydroxyl, alkoxy, aryloxy, phenyl, halogen, and amido group. The compound can be used in a therapeutic treatment of inflammatory related diseases and condition. |